Q3
Q3
Q3
Branch VI – PHARMACOLOGY
1. Polymorphism.
2. Street Drugs.
3. FDA Drug formulary during pregnancy.
4. Drug modifiers of G-protein coupled receptors.
5. Pre systemic metabolism.
6. Toxicity testing in animal models for teratogenicity.
7. Exploratory therapeutic trials.
8. Computer aided drug design.
9. Drug prescribing in renal insufficiency.
10. Substance abuse in sports.
*****
MAY 2011
I. Essay: (2X10=20)
1. Chronopharmacology
2. Therapeutic Drug Monitoring
3. Drug allergy
4. Tyrode solution
5. Pharmacovigilance
6. Anova
7. Alternatives to animal experiments
8. Drugs in pregnancy and lactation
1. Immunological tolerance
2. Drugs and blood brain barrier
3. Significance of liposomal drug delivery
4. Blinding in clinical trials
*******
[LD 125] OCTOBER 2013 Sub. Code: 2022
M.D. DEGREE EXAMINATION
BRANCH VI – PHARMACOLOGY
GENERAL PHARMACOLOGY, EXPERIMENTAL PHARMACOLOGY
AND BIOASSAY
Q.P. Code : 202022
Time: Three Hours Maximum: 100 marks
I. Essay: (2 x 10 = 20)
1. Discuss briefly the biotransformation of drugs.
2. Describe in detail transmembrane signaling mechanism .
II. Short Questions: ( 8 x 5 = 40)
1. Drug synergism.
2. Randomization.
3. Drug Tolerance.
4. Drug Accumulation.
5. Techniques used in gene therapy.
6. Idiosyncratic reactions.
7. Radio-Immuno Assay.
8. Volume of Distribution.
III. Reasoning Out: (4 x 5 = 20)
1. Spare receptors.
2. Drugs used in Pregnancy Hypertension.
3. Pharmacogenomics.
4. Structure activity relationship.
1. Write in details about the Drug Interactions. Mention the advantages and
disadvantages of fixed drug combinations.
2. Write in detail about the various preclinical & clinical screening procedures
for anti epileptics.
II. Short Questions: (8X5=40)
1. Phase II clinical trial
2. Clearance
3. Small animal anesthesia methods
4. DNA recombinant technique
5. Elisa use in pharmacological research
6. Randomization
7. Ion channel
8. Levers in preclinical research.
1. Solvents/vehicle
2. Body weight in drug treatment
3. Hoffman elimination
4. Apparent volume distribution
5. Pro drug
6. Micro dose
7. Nucleic acid receptor
8. Therapeutic paradox
9. Implants
10. Steady state concentration
*******